Clinical Trial Update: Treatment of Social and Language Deficits With Leucovorin for Young Children With Autism [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating leucovorin for social and language deficits in young children with autism. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Language Disorders

Drugs mentioned

• Leucovorin (folinic acid)

Snippet

Sponsor: Southwest Autism Research & Resource Center | Conditions: Autism Spectrum Disorder, Language Disorders | Phase 2 | Status: RECRUITING